Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2018.info:eu-repo/semantics/publishedVersio
AbstractProprotein convertase subtilisin/kexin type 9 (PCSK9) binds to the low-density lipoprotein r...
Hypercholesterolemia, is a prominent risk factor for cardiovascular disease (CVD). Undestanding of t...
Purpose of Review: Proprotein convertase subtilisin kexin 9 (PCSK9) plays a crucial role in regulati...
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2018...
The review presents the latest data from the world scientific literature of clinical studies of inhi...
This commentary refers to ‘2017 update of ESC/EAS task force on practical clinical guidance for prop...
PCSK9 (proprotein convertase subtilisin kexin 9) monoclonal antibodies (mAb) are new therapeutic age...
The first randomized controlled data from cardiovascular outcomes trials with proprotein convertase ...
Recent scientific and therapeutic advances in proprotein convertase subtilisin kexin type 9 (PCSK9) ...
Purpose of Review To report on recent data about PCSK9 monoclonal antibodies and to evaluate their r...
Elevated plasma LDL cholesterol (LDL-C) levels are associated with cardiovascular diseases and stati...
AbstractProprotein convertase subtilisin/kexin type 9 (PCSK9) binds to the low-density lipoprotein r...
Hypercholesterolemia, is a prominent risk factor for cardiovascular disease (CVD). Undestanding of t...
Purpose of Review: Proprotein convertase subtilisin kexin 9 (PCSK9) plays a crucial role in regulati...
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2018...
The review presents the latest data from the world scientific literature of clinical studies of inhi...
This commentary refers to ‘2017 update of ESC/EAS task force on practical clinical guidance for prop...
PCSK9 (proprotein convertase subtilisin kexin 9) monoclonal antibodies (mAb) are new therapeutic age...
The first randomized controlled data from cardiovascular outcomes trials with proprotein convertase ...
Recent scientific and therapeutic advances in proprotein convertase subtilisin kexin type 9 (PCSK9) ...
Purpose of Review To report on recent data about PCSK9 monoclonal antibodies and to evaluate their r...
Elevated plasma LDL cholesterol (LDL-C) levels are associated with cardiovascular diseases and stati...
AbstractProprotein convertase subtilisin/kexin type 9 (PCSK9) binds to the low-density lipoprotein r...
Hypercholesterolemia, is a prominent risk factor for cardiovascular disease (CVD). Undestanding of t...
Purpose of Review: Proprotein convertase subtilisin kexin 9 (PCSK9) plays a crucial role in regulati...